The Journal of Organic Chemistry
NOTE
1-sec-Butyl-cyclohex-2-enol (1e): 1H NMR (400 MHz,
CDCl3) δ 5.81À5.75 (m, 1H), 5.53À5.48 (d, J = 10.0 Hz, 1H),
2.02À1.97 (m, 1H), 1.97À1.93 (m, 1H), 1.89À1.79 (m, 1H),
1.74À1.70 (m, 2H), 1.63À1.58 (m, 2H), 1.55À1.45 (m, 2H),
1.36À1.29 (m, 1H), 0.89À0.77 (m, 7H); 13C NMR (100 MHz, CDCl3)
δ 132.8, 132.7, 130.5, 130.1, 72.0, 71.9, 45.2, 45.0, 30.7, 30.3, 25.3, 25.2,
24.6, 22.9, 18.54, 18.52, 13.9, 12.8, 12.7, 12.6; FTIR (neat) υ 3449, 3016,
2832, 1708, 1460, 1380, 1172, 1069, 850, 736 cmÀ1; HRMS (m/z) calcd
for C10H17 (MALDI-TOF, (M À OH)+) 137.1331, found 137.1330.
1-naphthalen-1-yl-cyclohex-2-enol (1k): 1H NMR (400
MHz, CDCl3) δ 8.84À8.81 (d, J = 7.5 Hz, 1H), 7.99À7.95 (d, J = 7.3
Hz, 1H), 7.90À7.86 (m, 2H), 7.61À7.57 (m, 2H), 7.56À7.51 (dd, J =
7.5 Hz, J = 7.8 Hz, 1H), 6.16À6.11 (dt, J = 10.0 Hz, J = 3.5 Hz, 1H),
6.06À6.02 (d, J = 10.0 Hz, 1H), 2.73 (s, br, 1H), 2.61À2.53 (m, 1H),
2.29À2.25 (m, 2H), 2.22À2.15 (m, 1H), 2.01À1.91 (m, 1H),
1.72À1.63 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 142.3, 135.0,
134.0, 130.7, 129.8, 129.2, 128.6, 126.8, 125.3, 125.2, 125.0, 124.9, 73.7,
37.3, 25.1, 19.6; FTIR (neat) υ 3419, 2924, 2855, 1458, 1377, 1167, 966,
904, 739 cmÀ1; HRMS (m/z) calcd for C16H15 (MALDI-TOF, (M À
OH)+) 207.1174, found 207.1179.
afford 2c (138 mg, 86%): 1H NMR (400 MHz, CDCl3) δ 7.42À7.50 (d,
J = 7.0 Hz, 2H), 7.21À7.33 (m, 3H), 6.20À6.23 (s, 1H), 4.97À5.02 (m,
1H), 2.81À2.84 (m, 1H), 2.60À2.63 (m, 1H), 2.40À2.42 (m, 1H),
1.81À1.84 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 146.1, 135.7,
128.5, 127.9, 127.3, 126.0, 77.0, 33.8, 31.4; FTIR (neat) ν 3406, 3079,
3055, 2935, 2246, 1947, 1877, 1802, 1737, 1598, 1493, 1069, 757 cmÀ1
;
HRMS (m/z) calcd for C11H11 (MALDI-TOF, (M À OH)+) 143.0861,
found 143.0868.
3-sec-Butylcyclohex-2-enol (2e). Prepared according to general
procedure A with 1e (154 mg) and 4a (14 mg) at room temperature to
1
afford 2e (134 mg, 87%): H NMR (400 MHz, CDCl3) δ 5.46À5.49
(m, 1H), 4.16À4.21 (m, 1H), 2.10À2.13 (br, 1H), 1.92À2.00 (m, 2H),
1.70À1.85 (m, 2H), 1.52À1.60 (m, 2H), 1.34À1.42 (m, 1H),
1.26À1.32 (m, 1H), 0.96À1.00 (d, J = 7.0 Hz, 3H), 0.85À0.90 (m,
1H), 0.79À0.85 (m, 3H); 13C NMR (100 MHz, CDCl3) δ 146.0, 123.4,
65.8, 42.5, 32.2, 27.6, 25.2, 19.2, 18.9, 11.8; FTIR (neat) ν 3360, 2660,
1709, 1662, 1456, 1059, 1023, 909, 759 cmÀ1; HRMS (m/z) calcd for
C10H17 (MALDI-TOF, (M À OH)+) 137.1331, found 137.1326.
3-tert-Butylcyclohex-2-enol (2f). Prepared according to general
procedure A with 1f (154 mg) and 4a (14 mg) at room temperature to
afford 2f (140 mg, 91%): 1H NMR (400 MHz, CDCl3) δ 5.53À5.55 (m,
1H), 4.18À4.23 (m, 1H), 1.90À2.10 (m, 2H), 1.76À1.84 (m, 1H),
1.66À1.59 (m, 1H), 1.52À1.58 (m, 2H), 1.48À1.51 (m, 1H),
1.01À1.04 (m, 9H); 13C NMR (100 MHz, CDCl3) δ 150.1, 120.3,
66.5, 35.3, 31.9, 28.8, 24.6, 19.9, 14.4; FTIR (neat) ν 3405, 3050, 2960,
2866, 1712, 1395, 1367, 1280, 1073, 1027, 999 cmÀ1; HRMS (m/z)
calcd for C10H17 (MALDI-TOF, (M À OH)+) 137.1331, found
137.1330.
1-Oct-1-ynyl-cyclohex-2-enol (7b): 1H NMR (400 MHz,
CDCl3) δ 5.60À5.58 (m, 2H), 2.07À2.02 (t, J = 7.3 Hz, 2H),
1.88À1.80 (m, 3H), 1.77À1.71 (m, 1H), 1.65À1.56 (m, 2H),
1.39À1.31 (m, 2H), 1.27À1.18 (m, 2H), 1.19À1.11 (m, 4H),
0.77À0.72 (t, J = 7.0 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ
131.4, 128.2, 84.1, 83.8, 65.0, 38.0, 31.2, 28.5, 28.4, 24.6, 22.4, 19.2,
18.6, 13.9; FTIR (neat) ν 3367. 2932, 2859, 2232, 1456, 1322, 1182,
1054, 959, 737 cmÀ1; HRMS (m/z) calcd for C14H21 (MALDI-TOF,
(M À OH)+) 189.1644, found 189.1638.
3-(4-Methoxyphenyl)cyclohex-2-enol (2g). Prepared accord-
ing to general procedure A with 1g (204 mg) and 4a (14 mg) at room
temperature to afford 2g (175 mg, 86%): 1H NMR (400 MHz, CDCl3)
δ 7.31À7.35 (d, J = 8.8 Hz, 2H), 6.83À6.86 (d, J = 8.8 Hz, 2H),
6.05À6.07 (m, 1H), 4.34À4.38 (m, 1H), 3.77 (s, 3H), 2.25À2.45 (m,
3H), 1.86À1.92 (m, 2H), 1.64À1.70 (m, 2H); 13C NMR (100 MHz,
CDCl3) δ 158.1, 138.7, 133.7, 126.1, 124.9, 113.4, 65.9, 54.9, 31.5, 27.2,
19.2; FTIR (Nujol) ν 3336, 3034, 2723, 2052, 1902, 1640, 1607, 1031,
966 cmÀ1; HRMS (m/z) calcd for C13H15O (MALDI-TOF, (M À
OH)+) 187.1123, found 187.1143.
1
3-Methyl-1-phenyl-hexa-1,4-dien-3-ol (7g): H NMR (400
MHz, CDCl3) δ 7.42À7.38 (m, 2H), 7.34À7.29 (m, 2H), 7.25À7.21
(m, 1H), 6.67À6.59 (m, 1H), 6.43À6.38 (d, J = 16.1 Hz, 0.5 H),
6.35À6.30 (d, J = 16.1 Hz, 0.5H), 5.73À5.57 (m, 2H), 2.19 (s, br, 1H),
1.83À1.80 (d, J = 5.5 Hz, 1.5H), 1.75À1.73 (d, J = 5.0 Hz, 1.5H), 1.54 (s,
1.5H), 1.48 (s, 1.5H); 13C NMR (100 MHz, CDCl3) δ 137.1, 137.0,
136.9, 135.89, 135.87, 135.8, 128.6, 128.5, 127.41, 127.39, 127.1, 126.81,
126.77, 126.5, 124.0, 73.4, 72.9, 30.0, 28.4, 17.8, 14.4; FTIR (neat) ν
3419, 3026, 2972, 2928, 1710, 1494, 1448, 1367, 969, 749, 694 cmÀ1
;
HRMS (m/z) calcd for C13H15 (MALDI-TOF, (M À OH)+) 171.1174,
3-(4-Trifluoromethylphenyl)cyclohex-2-enol (2h). Prepared
according to general procedure A with 1h (242 mg) and 4c (23 mg) at
found 171.1181.
1
General Procedure A for the rearrangement of allylic Alcohols. To a
10 mL round-bottom flask containing the substrate (1, 5, or 7, 1.0
mmol) in CH3CN (5 mL) and H2O (1 mL) was added catalyst 4a, b, or
c (0.1 mmol). The flask was either loosley capped with a septum and the
resulting mixture allowed to stir at room temperature for 16 h or fitted
with a condensor and heated to reflux for 16 h and cooled to room
temperature. A saturated solution of NaHCO3 (20 mL) was added and
the mixture extracted with Et2O (2 Â 25 mL). The combined organic
extracts were dried over MgSO4 and concentrated. Purification (if
necessary) of the residue by flash chromatography (EtOAc/hexanes)
afforded the products 2, 6, and 8.
room temperature to afford 2h (230 mg, 95%): H NMR (400 MHz,
CDCl3) δ 7.51À7.56 (d, J = 8.0 Hz, 2H), 7.45À7.49 (d, J = 8.2 Hz, 2H),
6.17À6.21 (s, 1H), 4.36À4.41 (s, 1H), 2.75À2.83 (s, 1H), 2.26À2.46
(m, 2H), 1.87À1.96 (m, 2H), 1.87À1.96 (m, 2H), 1.55À1.80 (m, 2H);
13C NMR (100 MHz, CDCl3) δ 143.3, 136.8, 127.4, 124.0, 123.5, 64.5,
29.8, 25.7, 17.8; FTIR (neat) ν 3350, 3025, 2936, 2865, 1921, 1616,
1410, 1071, 1016, 738 cmÀ1; HRMS (m/z) calcd for C13H12F3
(MALDI-TOF, (M À OH)+) 225.0891, found 225.0907.
3-o-Tolylcyclohex-2-enol (2i). Prepared according to general
procedure A with 1i (188 mg) and 4a (14 mg) at room temperature to
afford 2i (175 mg, 93%): 1H NMR (400 MHz, CDCl3) δ 7.02À7.15 (m,
5H), 4.31À4.35 (m, 1H), 2.10À2.34 (m, 6H), 1.82À1.95 (m, 2H),
1.66À1.72 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 143.0, 142.3,
134.6, 129.9, 128.2, 127.9, 126.7, 124.5, 65.7, 31.5, 30.2, 19.4, 19.5; FTIR
(neat) ν 3342, 3059, 3016, 2929, 2860, 1945, 1911, 1801, 1702, 1660,
1601, 1485, 1052, 756 cmÀ1; HRMS (m/z) calcd for C13H16 (MALDI-
TOF, (M À OH)+) 171.1174, found 171.1189.
3-Phenylcyclohept-2-enol (2b). Prepared according to general
procedure A with 1b (188 mg) and 4a (14 mg) at room temperature to
afford 2b (177 mg, 94%): 1H NMR (400 MHz, CDCl3) δ 7.22À7.32 (m,
4H), 7.15À7.21 (m, 1H), 5.96À6.01 (m, 1H), 4.52À4.57 (m, 1H),
2.72À2.82 (s, br, 1H), 2.58À2.62 (dd, J = 15.1 Hz, J = 6.5 Hz, 1H),
2.38À2.49 (m, 1H), 1.92À2.10 (m, 1H), 1.82À1.88 (m, 1H), 1.72À1.81
(m, 1H), 1.64À1.72 (m, 2H), 1.35À1.45 (m, 1H); 13C NMR (100 MHz,
CDCl3) δ143.9, 141.5, 136.0, 128.1, 126.0, 125.6, 71.8, 36.3, 32.5, 28.0, 26.1;
FTIR (neat) ν 3387, 3079, 3056, 3027, 2927, 2851, 1948, 1879, 1804, 1687,
1645, 1598, 1493, 1080, 761 cmÀ1; HRMS (m/z) calcd for C13H15
(MALDI-TOF, (M À OH)+) 171.1174, found 171.1166.
3-Naphthalen-2-ylcyclohex-2-enol (2j). Prepared according to
general procedure A with 1j (224 mg) and 4a (14 mg) at room
temperature to afford 2j (170 mg, 76%): 1H NMR (400 MHz, CDCl3)
δ 7.79À7.76 (dd, J = 6.3 Hz, J = 3.5 Hz, 1H), 7.75À7.71 (m, 4H),
7.70À7.66 (d, J = 8.5 Hz, 1H), 6.22À6.24 (m, 1H), 3.35À4.40 (m, 1H),
2.30À2.50 (m, 3H), 1.80À1.98 (m, 3H), 1.60À1.75 (m, 2H); 13C NMR
(100 MHz, CDCl3) δ 139.3, 138.3, 133.3, 132.6, 127.9, 127.6, 127.3,
3-Phenylcyclopent-2-enol (2c). Prepared according to general
procedure A with 1c (160 mg) and 4b (12 mg) at room temperature to
8540
dx.doi.org/10.1021/jo201540p |J. Org. Chem. 2011, 76, 8537–8542